220 related articles for article (PubMed ID: 22008025)
1. Yolk sac tumours revisited. A review of their many faces and names.
Nogales FF; Preda O; Nicolae A
Histopathology; 2012 Jun; 60(7):1023-33. PubMed ID: 22008025
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3.
Wang F; Liu A; Peng Y; Rakheja D; Wei L; Xue D; Allan RW; Molberg KH; Li J; Cao D
Am J Surg Pathol; 2009 Oct; 33(10):1529-39. PubMed ID: 19574883
[TBL] [Abstract][Full Text] [Related]
3. A diagnostic immunohistochemical panel for yolk sac (primitive endodermal) tumours based on an immunohistochemical comparison with the human yolk sac.
Nogales FF; Quiñonez E; López-Marín L; Dulcey I; Preda O
Histopathology; 2014 Jul; 65(1):51-9. PubMed ID: 24444105
[TBL] [Abstract][Full Text] [Related]
4. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma.
Cao D; Guo S; Allan RW; Molberg KH; Peng Y
Am J Surg Pathol; 2009 Jun; 33(6):894-904. PubMed ID: 19295406
[TBL] [Abstract][Full Text] [Related]
5. "Somatic-type" malignancies arising from testicular germ cell tumors: a clinicopathologic study of 124 cases with emphasis on glandular tumors supporting frequent yolk sac tumor origin.
Magers MJ; Kao CS; Cole CD; Rice KR; Foster RS; Einhorn LH; Ulbright TM
Am J Surg Pathol; 2014 Oct; 38(10):1396-409. PubMed ID: 24921638
[TBL] [Abstract][Full Text] [Related]
6. Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns.
Zynger DL; McCallum JC; Luan C; Chou PM; Yang XJ
Histopathology; 2010 May; 56(6):750-7. PubMed ID: 20546340
[TBL] [Abstract][Full Text] [Related]
7. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary.
Esheba GE; Pate LL; Longacre TA
Am J Surg Pathol; 2008 Apr; 32(4):600-7. PubMed ID: 18277882
[TBL] [Abstract][Full Text] [Related]
8. Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma.
Cheng L; Zhang S; Talerman A; Roth LM
Hum Pathol; 2010 May; 41(5):716-23. PubMed ID: 20096442
[TBL] [Abstract][Full Text] [Related]
9. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
[TBL] [Abstract][Full Text] [Related]
10. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
Ulbright TM
Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
[TBL] [Abstract][Full Text] [Related]
11. Glypican 3 is a sensitive, but not a specific, marker for the diagnosis of yolk sac tumours.
Preda O; Nicolae A; Aneiros-Fernández J; Borda A; Nogales FF
Histopathology; 2011 Jan; 58(2):312-4; author reply 314-5. PubMed ID: 21255065
[No Abstract] [Full Text] [Related]
12. The pioneer and differentiation factor FOXA2 is a key driver of yolk-sac tumour formation and a new biomarker for paediatric and adult yolk-sac tumours.
Wruck W; Bremmer F; Kotthoff M; Fichtner A; Skowron MA; Schönberger S; Calaminus G; Vokuhl C; Pfister D; Heidenreich A; Albers P; Adjaye J; Nettersheim D
J Cell Mol Med; 2021 Feb; 25(3):1394-1405. PubMed ID: 33448076
[TBL] [Abstract][Full Text] [Related]
13. Germ cell lineage differentiation in non-seminomatous germ cell tumours.
Honecker F; Stoop H; Mayer F; Bokemeyer C; Castrillon DH; Lau YF; Looijenga LH; Oosterhuis JW
J Pathol; 2006 Feb; 208(3):395-400. PubMed ID: 16273510
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical expression of SALL4 in hepatocellular carcinoma, a potential pitfall in the differential diagnosis of yolk sac tumors.
Gonzalez-Roibon N; Katz B; Chaux A; Sharma R; Munari E; Faraj SF; Illei PB; Torbenson M; Netto GJ
Hum Pathol; 2013 Jul; 44(7):1293-9. PubMed ID: 23347651
[TBL] [Abstract][Full Text] [Related]
15. Gonadoblastoma and hepatoid and endometrioid-like yolk sac tumor: an update.
Ulbright TM
Int J Gynecol Pathol; 2014 Jul; 33(4):365-73. PubMed ID: 24901396
[TBL] [Abstract][Full Text] [Related]
16. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors.
Cao D; Humphrey PA; Allan RW
Cancer; 2009 Jun; 115(12):2640-51. PubMed ID: 19365862
[TBL] [Abstract][Full Text] [Related]
17. Transcription factor GATA-4 is expressed in pediatric yolk sac tumors.
Siltanen S; Anttonen M; Heikkilä P; Narita N; Laitinen M; Ritvos O; Wilson DB; Heikinheimo M
Am J Pathol; 1999 Dec; 155(6):1823-9. PubMed ID: 10595911
[TBL] [Abstract][Full Text] [Related]
18. Transcription factor GATA-6 is expressed in malignant endoderm of pediatric yolk sac tumors and in teratomas.
Siltanen S; Heikkilä P; Bielinska M; Wilson DB; Heikinheimo M
Pediatr Res; 2003 Oct; 54(4):542-6. PubMed ID: 12867597
[TBL] [Abstract][Full Text] [Related]
19. The use of cytokeratin 7 and EMA in differentiating ovarian yolk sac tumors from endometrioid and clear cell carcinomas.
Ramalingam P; Malpica A; Silva EG; Gershenson DM; Liu JL; Deavers MT
Am J Surg Pathol; 2004 Nov; 28(11):1499-505. PubMed ID: 15489654
[TBL] [Abstract][Full Text] [Related]
20. [The problems of yolk sac tumor morphogenesis in a light of the tumor stem cell theory].
Karseladze AI
Arkh Patol; 2011; 73(4):29-33. PubMed ID: 22164428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
